Sofwave Medical Inc

Sofwave Medical's journey began in 2015, born from the visionary minds of Dr. Shimon Eckhouse and Ariel Sverdlik in the Alon Medtech Ventures incubator in Yokneam, Israel. Dr. Eckhouse, often hailed as a pioneer in the medical aesthetics field, sought to revolutionize non-invasive skin treatments. Together with Sverdlik, they developed the proprietary Synchronous Ultrasound Parallel Beam (SUPERB™) technology, a breakthrough designed to address the growing demand for effective, non-invasive aesthetic solutions.

From its early days in the incubator, Sofwave rapidly evolved from a promising concept into a global leader in the medical device industry. The company's commitment to innovation led to the development of a unique ultrasound delivery system that stimulates the production of new collagen and elastin with minimal downtime for patients. This dedication to clinical excellence resulted in multiple FDA clearances, including treatments for fine lines, wrinkles, and cellulite, propelling the company onto the global stage.

Today, Sofwave has expanded its footprint significantly, establishing a strong presence in the United States with headquarters in San Clemente, California, while maintaining its R&D and manufacturing roots in Israel. The company's successful IPO on the Tel Aviv Stock Exchange (TASE) marked a significant milestone in its growth story, validating its technology and market potential. With a growing portfolio of innovative products and a dedicated team of experts, Sofwave continues to ride the wave of success, reshaping the future of aesthetic medicine for providers and patients worldwide.